Dr. Elena Itskovich hosts Dr. Marco Quarta and Dr. Paul Robbins to discuss the groundbreaking field of Senolytics research and therapeutic development. They discuss how this cutting-edge research is reshaping the landscape of medicine and offering new hope for age-related diseases.

Join us in this thought-provoking episode as we learn more about the goals and objectives of the Senolytics Summit by the Phaedon Institute, a highly curated and professional forum that brings together stakeholders from academia, biotechnology, pharmaceuticals, investors, and regulatory bodies to promote advances in the field, support collaboration and coordination, and accelerate research for the benefit of the aging population affected by chronic degenerative diseases.

Find more information https://phaedon.institute

Guests -

Dr. Marco Quarta - CEO of Rubedo Life Sciences, Co-founder and Director of the Board of Turn Biotechnologies and the founder of the Phaedon Institute and chair of it’s scientific committee.

Dr. Paul Robbins - Professor of Biochemistry, Molecular Biology and Biophysics and Associate Director of the Institute on the Biology of Aging and Metabolism at the University of Minnesota. His current research is focused on developing therapeutic approaches to extend healthspan including senotherapeutics.

Host -

Dr. Elena Itskovich, an advisor to the Phaedon institue, Co-founder and President of Nest Catalyst , and the host of the mAcademia podcast.

----

The Phaedon Institute is a nonprofit, charitable organization that operates with the mission of supporting and enabling an effective and sustainable growth of the field of aging and longevity sciences and therapeutics.

The Phaedon Podcast is one of the ways in which we form connections between the different stakeholders in aging research and therapeutics as well as keep an open route of information sharing between aging and longevity experts and the public.

Music

"Guts and Bourbon" Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 4.0 License
http://creativecommons.org/licenses/by/4.0/